Baylor Research Institute

Summary

Baylor Research Institute is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, Heart Failure, Glioblastoma, Brain Tumor, Lymphoma and other specialties. Baylor Research Institute is involved with conducting 148 clinical trials across 262 conditions. There are 24 research doctors associated with this hospital, such as Gary Schwartz, MD, Molly Szerlip, MD, Scott Paulson, MD, and Moshe Yair Levy.

Top PIs

Clinical Trials running at Baylor Research Institute

Heart Failure

Stroke

Esophageal Cancer

Brain Cancer

Atrial Fibrillation

High Blood Pressure

Bladder Cancer

Peripheral Arterial Disease

Lung Cancer

Squamous Cell Carcinoma

AccuCinch System

for Heart Failure

This trial is testing a new device called the AccuCinch Ventricular Restoration System in patients with a specific type of heart failure. The device helps the heart pump blood more effectively by supporting and reshaping its lower chamber. The study aims to see if this device, combined with standard medical treatment, is safe and effective. The CorCap Cardiac Support Device (CSD) is a predecessor that has shown safety and effectiveness in improving left ventricular structure and function in heart failure patients.

Recruiting

1 award

N/A

9 criteria

Mavacamten

for Hypertrophic Cardiomyopathy

This registry evaluates patient characteristics, real-world treatment patterns, and short- and long-term outcomes in a population of patients in the United States and Europe with symptomatic obstructive hypertrophic cardiomyopathy (HCM) who are receiving mavacamten, receiving other treatment for obstructive HCM, or not receiving treatment for obstructive HCM due to intolerance or failure of prior treatment. United States Sub-Study: The purpose of this study is to evaluate the safety of mavacamten in patients with symptomatic obstructive HCM in the real-world setting. Europe Sub-Study: The purpose of this study is to evaluate the effectiveness and safety of mavacamten in patients with symptomatic obstructive HCM in the real-world setting.

Recruiting

1 award

N/A

10 criteria

CCM Therapy

for Heart Failure

This trial tests a device that helps the heart pump better in patients with moderate heart failure. It targets those whose heart's pumping ability is moderately reduced. The device works by giving the heart small electrical boosts. Several new devices for the treatment of heart failure patients have been introduced and are increasingly used in medical practice or are under evaluation.

Recruiting

0 awards

N/A

7 criteria